Home	Publications	Projects	Software

Publications

• Role of Intracellular Drug Disposition in the Response of Acute Myeloid Leukemia to Cytarabine and Idarubicin Induction Chemotherapy. (2023)

• Metabolic subtypes of nonalcoholic fatty liver disease patients exhibit distinctive cardiovascular risk profiles. (2022)

• A Novel Serum Metabolomic Profile for the Differential Diagnosis of Distal Cholangiocarcinoma and Pancreatic Ductal Adenocarcinoma. (2020)

• Agonist of RORA Attenuates Nonalcoholic Fatty Liver Progression in Mice via Up-regulation of MicroRNA 122. (2020)

• CA19-9 capability as predictor of pancreatic cancer resectability in a Spanish cohort. (2020)

• The lipidome of endometrial fluid differs between implantative and non-implantative IVF cycles. (2020)

• Metabolomics Discloses a New Non-invasive Method for the Diagnosis and Prognosis of Patients with Alcoholic Hepatitis. (2019)

• Plasma MicroRNA Signature Validation for Early Detection of Colorectal Cancer. (2019)

• Metabolomics discloses potential biomarkers to predict the acute HVPG response to propranolol in patients with cirrhosis. (2019)

• Metabolomics discloses potential biomarkers to predict the acute HVPG response to propranolol in patients with cirrhosis. (2019)

• Serum Metabolites as Diagnostic Biomarkers for Cholangiocarcinoma, Hepatocellular Carcinoma, and Primary Sclerosing Cholangitis. (2019)

• Obeticholic Acid Modulates Serum Metabolites and Gene Signatures Characteristic of Human NASH and Attenuates Inflammation and Fibrosis Progression in Ldlr-/-.Leiden Mice. (2018)

• Targeted UPLC-MS Metabolic Analysis of Human Faeces Reveals Novel Low-Invasive Candidate Markers for Colorectal Cancer. (2018)

• Metabolomic-based noninvasive serum test to diagnose nonalcoholic steatohepatitis: Results from discovery and validation cohorts. (2018)

• Use of a metabolomic approach to non-invasively diagnose non-alcoholic fatty liver disease in patients with type 2 diabetes mellitus. (2018)

• Role of Aramchol in steatohepatitis and fibrosis in mice. (2017)

• A Metabolomics Signature Linked To Liver Fibrosis In The Serum Of Transplanted Hepatitis C Patients. (2017)

• Metabolomic Identification of Subtypes of Nonalcoholic Steatohepatitis. (2017)

• Data in support of enhancing metabolomics research through data mining. (2015)

• Enhancing metabolomics research through data mining. (2015)

• Excess S-adenosylmethionine reroutes phosphatidylethanolamine towards phosphatidylcholine and triglyceride synthesis. (2013)

• Solute carrier family 2 member 1 is involved in the development of nonalcoholic fatty liver disease. (2013)

• Obesity-Dependent Metabolic Signatures Associated with Nonalcoholic Fatty Liver Disease Progression. (2012)

back